2 weeks Sinovac COVID vaccine cleared for Phase 3 trial MB
A COVID-19 vaccine candidate developed by China’s Sinovac Biotech has passed the review of the Philippines’ vaccine experts panel for clinical trials in the country, the Food and Drug Administration (FDA) bared Thursday. (NOEL CELIS / AFP / MANILA BULLETIN) FDA Director General Rolando Enrique Domingo said that the vaccine experts panel, chaired by the Department of Science and Technology, has cleared Sinovac for Phase 3 clinical trials. However, the Chinese firm still needs to get an approval from the Philippines’ Ethics Board Committee before it can apply for the FDA for an application for clinical trials. Domingo said ... more